North America Medical Enzyme Technology Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Enzyme Type (Digestive Enzymes, Thrombolytic Enzymes, Hydrolases, and Endonucleases); Application (Disease Treatment, Diagnostic Tools, Biomedical Research, and Others)
Market Introduction
Enzymes are proteins produced in living cells of plants, animals, and microorganisms. All living organisms require enzymes for growth and for the production and utilization of energy which is essential for life. In the living cell, enzymes act as catalysts to speed up the chemical reactions which control life processes. Enzymes have been significant industrial products for more than a hundred years. However, the range of potential applications is increasing rapidly. With the advent of recombinant DNA technology, it has become possible to make formerly rare enzymes in large quantities and hence to reduce cost. Also, in pharmaceutical manufacturing, the desire to make chirally pure compounds is leading to new opportunities. Technological advances have facilitated the use of enzymes over an increasingly broad range of process conditions.
Thus, the significant increase in research and development activities is expected to create a significant demand for medical enzyme technology in the coming years, which is further anticipated to drive the medical enzyme technology market.
In the North American region, the US was profoundly affected by the outbreak of the COVID-19 pandemic. The country has marked the highest number of positive patients and still facing the second wave of COVID-19. Across the various healthcare sectors, the effect of a pandemic can be felt, resulting in various changes in the health care industry. Scientists are working together to produce and exchange genomic sequence data information, which can be used in disease detection and control efforts. The US is increasing its ability to track coronavirus mutations and has demand for digestive enzymes. It has also been documented that SARS-CoV-2 infection can cause liver damage, and that abnormal liver function and liver enzymes are associated with the severity of COVID-19. Extreme COVID-19 patients have higher levels of aspartate aminotransferase, alanine aminotransferase, and total bilirubin (TBL) than non-severe COVID-19 patients. Elevated hepatic enzymes are also more common in COVID-19 patients treated in the ICU compared to those not treated in the ICU. During the treatment of the first COVID-19 confirmed case in the United States, there was an overall increase in hepatic enzymes, indicating that SARS-CoV-2 infection would directly affect the liver. All such aspects will add to the future demand for the North America region's Medical Enzyme Technology market.
Get more information on this report :
Market Overview and Dynamics
The Medical enzyme technology market in North America is expected to grow from US$ 1,783.1 million in 2021 to US$ 2,857.6 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2021 to 2028. Biopharmaceuticals are among the growing business segments of the pharmaceutical and biotechnology industries. Since their introduction in 1982, biopharmaceutical drugs have revolutionized the treatment of a broad spectrum of diseases, and they are increasingly used in nearly all medicine branches. Despite the immense time and financial effort required, the market of biopharmaceuticals is rapidly growing. In 2017, India-based Biocon received the US Food and Drug Administration (FDA) approval for Ogivri, a biosimilar to Herceptin (trastuzumab). That is the first biosimilar approved in the US to treat breast and stomach cancer and the second biosimilar approved in the country for cancer treatment.
Key Market Segments
In terms of enzyme type, the hydrolases segment accounted for the largest share of the North America medical enzyme technology market in 2020. In terms of application, the disease treatment segment accounted for the largest share of the North America medical enzyme technology market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the medical enzyme technology market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Merck Kgaa, Thermo Fisher Scientific Inc., Novozymes, Takeda Pharmaceutical Company Limited, Agilent Technologies, Inc., Genzyme Corporation, Asahi Kasei Corporation, Promega Corporation, Cytiva, and Amano Enzyme Inc.
Reasons to buy report
- To understand the North America Medical enzyme technology market landscape and identify market segments that are most likely to guarantee a strong return
- Stay ahead of the race by comprehending the ever-changing competitive landscape for North America Medical enzyme technology market
- Efficiently plan M&A and partnership deals in North America Medical enzyme technology market by identifying market segments with the most promising probable sales
- Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America Medical enzyme technology market
- Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.
NORTH AMERICA MEDICAL ENZYME TECHNOLOGY MARKET SEGMENTATION
By Enzyme Type
- Digestive Enzymes
- L-asparaginase
- Lactase
- Others
- Thrombolytic Enzymes
- Streptokinase
- Urokinase
- Others
- Hydrolases Enzymes
- Hyaluronidase
- Lysozymes
- Others
- Endonucleases Enzymes
- Benzonase
- Others
By Application
- Disease Treatment
- Diagnostic Tools
- Biomedical Research
- Others
By Country
- North America
- US
- Canada
- Mexico
Companies Mentioned
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Medical Enzyme Technology Market – By Enzyme Type
1.3.2 Medical Enzyme Technology Market – By Application
1.3.3 North America Medical Enzyme Technology Market – By Country
2. North America Medical Enzyme Technology Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Medical Enzyme Technology Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 Medical Enzyme Technology Market- North America PEST Analysis
4.3 Expert Opinion
5. North America Medical Enzyme Technology Market - Key Market Dynamics
5.1 Market Drivers
5.1.1 Applications of Enzymes in Diagnosis and Disease Treatment
5.1.2 Significant Increase in Research and Development Activities
5.2 Market Restraints
5.2.1 Handling and Safety Issues Related to Enzymes
5.3 Market Opportunities
5.3.1 Rising Production of Biopharmaceutical Products
5.4 Future Trends
5.4.1 Advancements in Enzyme Engineering
5.5 Impact Analysis
6. Medical Enzyme Technology Market – North America Analysis
6.1 North America Medical Enzyme Technology Market Revenue Forecasts and Analysis
7. North America Medical Enzyme Technology Market Analysis and Forecasts To 2028 – By Enzyme Type
7.1 Overview
7.2 Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020–2028)
7.3 Digestive Enzymes
7.3.1 Overview
7.3.2 Digestive Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.3 L-asparaginase Market
7.3.3.1 Overview
7.3.3.2 L-asparaginase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.4 Lactase Market
7.3.4.1 Overview
7.3.4.2 Lactase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.3.5 Others Market
7.3.5.1 Overview
7.3.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4 Thrombolytic Enzymes
7.4.1 Overview
7.4.2 Thrombolytic Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.3 Streptokinase Market
7.4.3.1 Overview
7.4.3.2 Streptokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.4 Urokinase Market
7.4.4.1 Overview
7.4.4.2 Urokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.4.5 Others Market
7.4.5.1 Overview
7.4.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5 Hydrolases Enzymes
7.5.1 Overview
7.5.2 Hydrolases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.3 Hyaluronidase Market
7.5.3.1 Overview
7.5.3.2 Hyaluronidase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.4 Lysozymes Market
7.5.4.1 Overview
7.5.4.2 Lysozymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.5.5 Others Market
7.5.5.1 Overview
7.5.5.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6 Endonucleases
7.6.1 Overview
7.6.2 Endonucleases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6.3 Benzonase
7.6.3.1 Overview
7.6.3.2 Benzonase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
7.6.4 Others
7.6.4.1 Overview
7.6.4.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8. Medical Enzyme Technology Market Analysis – By Application
8.1 Overview
8.2 Medical Enzyme Technology Market Revenue Share, by Application (2020–2028)
8.3 Disease Treatment
8.3.1 Overview
8.3.2 Disease Treatment: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.4 Diagnostic Tools
8.4.1 Overview
8.4.2 Diagnostic Tools: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.5 Biomedical Research
8.5.1 Overview
8.5.2 Biomedical Research: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
9. Medical Enzyme Technology Market Revenue and Forecasts to 2028 – Geographical Analysis
9.1 North America
9.1.1 Overview
9.1.2 North America: Medical Enzyme Technology Market, by Country, 2020 & 2028 (%)
9.1.2.1 US
9.1.2.1.1 US: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.1.2 US: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.2.1.2.1 US: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.2.1.2.2 US: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.2.1.2.3 US: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.2.1.2.4 US: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.2.1.3 US: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.2.2 Canada
9.1.2.2.1 Canada: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.2.2 Canada: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.2.2.2.1 Canada: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.2.2.2.2 Canada: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.2.2.2.3 Canada: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.2.2.2.4 Canada: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.2.2.3 Canada: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
9.1.2.3 Mexico
9.1.2.3.1 Mexico: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
9.1.2.3.2 Mexico: Medical Enzyme Technology Market, by Enzyme Type, 2019–2028 (USD Million)
9.1.2.3.2.1 Mexico: Medical Enzyme Technology Market, by Hydrolases, 2019–2028 (USD Million)
9.1.2.3.2.2 Mexico: Medical Enzyme Technology Market, by Thrombolytic Enzymes, 2019–2028 (USD Million)
9.1.2.3.2.3 Mexico: Medical Enzyme Technology Market, by Digestive Enzymes, 2019–2028 (USD Million)
9.1.2.3.2.4 Mexico: Medical Enzyme Technology Market, by Endonucleases, 2019–2028 (USD Million)
9.1.2.3.3 Mexico: Medical Enzyme Technology Market, by Application, 2019–2028 (USD Million)
10. Impact Of COVID-19 Pandemic on North America Medical Enzyme Technology Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies Done by the Companies in the Market, (%)
11.3 Organic Developments
11.3.1 Overview
11.3.2 Organic Developments Done by Companies
11.4 Inorganic Developments
11.4.1 Overview
11.4.2 Inorganic Developments Done by Companies
12. COMPANY PROFILES
12.1 MERCK KGaA
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 WOT Analysis
12.1.6 Key Developments
12.2 THERMO FISHER SCIENTIFIC INC.
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Novozymes
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Takeda Pharmaceutical Company Limited
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Agilent Technologies, Inc.
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Genzyme Corporation
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Asahi Kasei Corporation
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Promega Corporation
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Cytiva
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Amano Enzyme Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About the Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. US: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 2. US: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 3. US: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 4. US: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 5. US: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 6. US: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Canada: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 8. Canada: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 9. Canada: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 10. Canada: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 11. Canada: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 12. Canada: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 13. Mexico: Medical Enzyme Technology Market, by Enzyme Type– Revenue and Forecast to 2028 (USD Million)
Table 14. Mexico: Medical Enzyme Technology Market, by Hydrolases– Revenue and Forecast to 2028 (USD Million)
Table 15. Mexico: Medical Enzyme Technology Market, by Thrombolytic Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 16. Mexico: Medical Enzyme Technology Market, by Digestive Enzymes– Revenue and Forecast to 2028 (USD Million)
Table 17. Mexico: Medical Enzyme Technology Market, by Endonucleases– Revenue and Forecast to 2028 (USD Million)
Table 18. Mexico: Medical Enzyme Technology Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 19. Glossary of Terms, Medical Enzyme Technology Market
LIST OF FIGURES
Figure 1. Medical Enzyme Technology Market Segmentation
Figure 2. North America Medical Enzyme Technology Market Overview
Figure 3. Hydrolases Segment Held Largest Share of Enzyme Type in Medical Enzyme Technology Market
Figure 4. US is Expected to Show Remarkable Growth During the Forecast Period
Figure 5. Medical Enzyme Technology Market - North America PEST Analysis
Figure 6. Medical Enzyme Technology Market Impact Analysis of Driver and Restraints
Figure 7. North America Medical Enzyme Technology Market – Revenue Forecasts and Analysis – 2020- 2028
Figure 8. Medical Enzyme Technology Market Revenue Share, by Enzyme Type (2020–2028)
Figure 9. Digestive Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 10. L-asparaginase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 11. Lactase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 12. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 13. Thrombolytic Enzymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 14. Streptokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 15. Urokinase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 17. Hydrolases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 18. Hyaluronidase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 19. Lysozymes: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 20. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 21. Endonucleases: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 22. Benzonase: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 23. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 24. Medical Enzyme Technology Market Revenue Share, by Application (2020–2028)
Figure 25. Disease Treatment: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 26. Diagnostic Tools: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 27. Biomedical Research: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 28. Others: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (US$ Million)
Figure 29. North America: Medical Enzyme Technology Market, by Key Country – Revenue (2020) (USD Million)
Figure 30. North America: Medical Enzyme Technology Market, by Country, 2020 & 2028 (%)
Figure 31. US: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Canada: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Mexico: Medical Enzyme Technology Market – Revenue and Forecast to 2028 (USD Million)
Figure 34. Impact of COVID-19 Pandemic in North American Country Markets
Figure 35. Growth Strategies Done by the Companies in the Market, (%)
- Merck Kgaa
- Thermo Fisher Scientific Inc.
- Novozymes
- Takeda Pharmaceutical Company Limited
- Agilent Technologies, Inc.
- Genzyme Corporation
- Asahi Kasei Corporation
- Promega Corporation
- Cytiva
- Amano Enzyme Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America medical enzyme technology market.
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America medical enzyme technology market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the medical enzyme technology market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution